{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:39:48Z","timestamp":1785296388381,"version":"3.55.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260711-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Patients with metabolic dysfunction\u2013associated steatotic liver disease (MASLD) are at increased risk for colorectal neoplasia. It remains unclear whether dynamic improvements in metabolic health can prevent metachronous advanced colorectal neoplasia (ACRN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260711-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether longitudinal reduction of cardiometabolic risk factors (CMRFs) is associated with a decreased risk of metachronous ACRN among patients with MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260711-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study of patients who underwent initial and surveillance colonoscopy between January 2009 and December 2021 was conducted at a large tertiary referral center in Taiwan. Data analysis was performed from March 2024 to March 2026. Individuals at least 40 years of age with MASLD who underwent successful removal of at least 1 colorectal adenoma and had a minimum follow-up of 1 year were screened. Patients with a history of colorectal cancer, inflammatory bowel disease, or hereditary polyposis syndromes were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260711-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Changes in the number of CMRFs (abdominal obesity, hypertriglyceridemia, low high-density lipoprotein cholesterol, hypertension, and impaired fasting glucose) between baseline and surveillance. Participants were grouped by the direction of CMRF count change (reduced, increased, or unchanged).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260711-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was metachronous ACRN, defined as a metachronous adenoma of at least 10 mm in diameter with villous components or high-grade dysplasia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260711-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 8258 patients initially screened, 2331 met all criteria and completed the surveillance protocol. Among 2331 included participants (mean [SD] age, 56.7 [8.8] years; 1745 [74.9%] male) with a mean (SD) follow-up 4.0 (2.5) years, the incidence of metachronous ACRN per 1000 patient-years was 16.7 (95% CI, 11.4-23.6) with increased CMRFs, 17.6 (95% CI, 12.9-23.9) with an unchanged number of CMRFs, 11.9 (95% CI, 8.3-16.4) with the reduction of 1 CMRF, and 9.9 (95% CI, 5.8-15.7) with the reduction of at least 2 CMRFs (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.03). Multivariable analysis showed that CMRF reduction was associated with a significantly lower risk of metachronous ACRN (adjusted hazard ratio [AHR], 0.49 [95% CI, 0.33-0.73];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). In high-risk subgroups, a decrease in the number of CMRFs was associated with risk reduction (5 CMRFs group: AHR, 0.40 [95% CI, 0.17-0.92];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.03; baseline ACRN group: AHR, 0.27 [95% CI, 0.11-0.65];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.003).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260711-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of 2331 patients with MASLD, longitudinal CMRF reduction was associated with lower metachronous ACRN risk, suggesting that metabolic optimization should be integrated with endoscopic surveillance as a primary prevention strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.25715","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:30:15Z","timestamp":1785252615000},"page":"e2625715","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic Optimization and Risk of Metachronous Advanced Colorectal Neoplasia in Patients With MASLD"],"prefix":"10.1001","volume":"9","author":[{"given":"Wei-Yuan","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Health Management Center, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"Health Data Research Center, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Ho","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Cancer Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu-Hua","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Bi-Chun","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chun","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Health Management Center, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Feng","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Mo","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Health Management Center, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Comprehensive Approach to Risk Evaluation and Elimination of Subhealth (CARES) Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jen","family":"Liu","sequence":"additional","affiliation":[{"name":"for the Comprehensive Approach to Risk Evaluation and Elimination of Subhealth (CARES) Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Chung","family":"Tseng","sequence":"additional","affiliation":[{"name":"for the Comprehensive Approach to Risk Evaluation and Elimination of Subhealth (CARES) Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Ju","family":"Lin","sequence":"additional","affiliation":[{"name":"for the Comprehensive Approach to Risk Evaluation and Elimination of Subhealth (CARES) Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"6","key":"zoi260711r1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"8","key":"zoi260711r2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD.","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"zoi260711r3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment.","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"zoi260711r4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/aje\/kwaa005","article-title":"Smoking-related risks of colorectal cancer by anatomical subsite and sex.","volume":"189","author":"Gram","year":"2020","journal-title":"Am J Epidemiol"},{"issue":"19","key":"zoi260711r5","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e158","article-title":"Association of physical activity and sedentary behavior with the risk of colorectal cancer.","volume":"37","author":"An","year":"2022","journal-title":"J Korean Med Sci"},{"issue":"6","key":"zoi260711r6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","article-title":"Obesity and colorectal cancer.","volume":"62","author":"Bardou","year":"2013","journal-title":"Gut"},{"issue":"6","key":"zoi260711r7","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1007\/s10620-012-2055-1","article-title":"Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis.","volume":"57","author":"Deng","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"3","key":"zoi260711r8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s12020-013-9939-5","article-title":"Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.","volume":"44","author":"Esposito","year":"2013","journal-title":"Endocrine"},{"issue":"6","key":"zoi260711r9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1136\/gutjnl-2020-321661","article-title":"Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer.","volume":"70","author":"Chen","year":"2021","journal-title":"Gut"},{"issue":"11","key":"zoi260711r10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-104934","article-title":"Metabolic dysfunction-associated steatotic liver disease and colorectal neoplasms risk: a global propensity score-matched retrospective cohort study.","volume":"15","author":"Aldiabat","year":"2025","journal-title":"BMJ Open"},{"issue":"3","key":"zoi260711r11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3904\/kjim.2019.360","article-title":"Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy.","volume":"36","author":"Kim","year":"2021","journal-title":"Korean J Intern Med"},{"issue":"6","key":"zoi260711r12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.cgh.2014.10.022","article-title":"Effects of metabolic syndrome and findings from baseline colonoscopies on occurrence of colorectal neoplasms.","volume":"13","author":"Chiu","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"zoi260711r13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1055\/s-0032-1309837","article-title":"Obesity, weight change, and risk of adenoma recurrence: a prospective trial.","volume":"44","author":"Laiyemo","year":"2012","journal-title":"Endoscopy"},{"issue":"8","key":"zoi260711r14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa1100370","article-title":"Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.","volume":"366","author":"Zauber","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi260711r15","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1053\/j.gastro.2006.03.012","article-title":"Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.","volume":"130","author":"Winawer","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"zoi260711r16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1053\/j.gastro.2012.06.001","article-title":"Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.","volume":"143","author":"Lieberman","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"zoi260711r17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1053\/j.gastro.2019.10.026","article-title":"Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.","volume":"158","author":"Gupta","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"zoi260711r18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1055\/a-1185-3109","article-title":"Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - update 2020.","volume":"52","author":"Hassan","year":"2020","journal-title":"Endoscopy"},{"issue":"2","key":"zoi260711r20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system.","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"2","key":"zoi260711r21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.14309\/ajg.0000000000002915","article-title":"Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B.","volume":"120","author":"Huang","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"zoi260711r22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.3567","article-title":"Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failure.","volume":"27","author":"Chang","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"zoi260711r23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The inflammatory pathogenesis of colorectal cancer.","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"zoi260711r24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clnesp.2018.08.007","article-title":"Weight loss is a critical factor to reduce inflammation.","volume":"28","author":"Bianchi","year":"2018","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"zoi260711r25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2741\/s142","article-title":"Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome.","volume":"3","author":"Beavers","year":"2011","journal-title":"Front Biosci (Schol Ed)"},{"issue":"4-5","key":"zoi260711r26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bpg.2011.10.015","article-title":"Aspirin for the prevention of colorectal cancer.","volume":"25","author":"Garcia-Albeniz","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"zoi260711r27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/jamaoncol.2020.7338","article-title":"Aspirin use and risk of colorectal cancer among older adults.","volume":"7","author":"Guo","year":"2021","journal-title":"JAMA Oncol"},{"key":"zoi260711r28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1162221","article-title":"Association of modifiable lifestyle with colorectal cancer incidence and mortality according to metabolic status: prospective cohort study.","volume":"13","author":"Xie","year":"2023","journal-title":"Front Oncol"},{"issue":"8","key":"zoi260711r29","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1111\/j.1572-0241.2008.01936.x","article-title":"The effect of body weight reduction on the incidence of colorectal adenoma.","volume":"103","author":"Yamaji","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"zoi260711r30","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamaoncol.2024.2503","article-title":"Aspirin use and incidence of colorectal cancer according to lifestyle risk.","volume":"10","author":"Sikavi","year":"2024","journal-title":"JAMA Oncol"},{"issue":"26","key":"zoi260711r31","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e199","article-title":"Relationship between aspirin use and site-specific colorectal cancer risk among individuals with metabolic comorbidity.","volume":"39","author":"An","year":"2024","journal-title":"J Korean Med Sci"},{"key":"zoi260711r19","volume-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010","edition":"4th ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852140\/chang_2026_oi_260711_1784645743.31625.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:30:16Z","timestamp":1785252616000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.25715","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}